Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$1.60
-$0.07-4.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.38M | 6.70M | 4.66M | 4.08M | 3.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.91M | 11.69M | 9.26M | 7.70M | 7.20M |
| Operating Income | -10.91M | -11.69M | -9.26M | -7.70M | -7.20M |
| Income Before Tax | -10.71M | -12.14M | -10.47M | -9.14M | -9.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.71 | -12.14 | -10.47 | -9.14 | -9.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.71M | -12.14M | -10.47M | -9.14M | -9.19M |
| EBIT | -10.91M | -11.69M | -9.26M | -7.70M | -7.20M |
| EBITDA | -10.90M | -11.69M | -9.26M | -7.69M | -7.20M |
| EPS Basic | -20.07 | -58.85 | -79.69 | -92.94 | -105.26 |
| Normalized Basic EPS | -12.55 | -31.86 | -44.97 | -52.74 | -60.85 |
| EPS Diluted | -21.94 | -60.72 | -81.56 | -94.81 | -105.26 |
| Normalized Diluted EPS | -12.55 | -31.86 | -44.97 | -52.74 | -60.85 |
| Average Basic Shares Outstanding | 3.96M | 1.82M | 777.70K | 458.70K | 342.40K |
| Average Diluted Shares Outstanding | 3.96M | 1.82M | 777.70K | 458.70K | 342.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |